NANJING, China, July 25, 2025 -- On 25 July, 2025 (China Time), Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company") listed on the Main Board of The Stock Exchange of Hong Kong Limited (HKEX) under the stock code "09887". The clinical-stage biotech company priced its IPO at HKD 35 per share, offering 36.86 million shares (excluding green shoe option). The deal included a Hong Kong public tranche of 16.03 million shares (43% of the total) and an international placement of 20.84 million shares (57%). Morgan Stanley and CITIC Securities acted as
Johor plant is Colorcon's 7th major film coating plant and 16th manufacturing facility worldwide HARLEYSVILLE, Pa. and JOHOR, Malaysia, July 24, 2025 -- Colorcon, a global leader of film coating systems, specialty excipients, controlled release formulations and controlled atmosphere packaging for the pharmaceutical and nutraceutical industries, today announced the grand opening of a new, state-of-the-art film coating manufacturing facility in Johor Malaysia. The 200,000 square-foot facility will immediately employ 30 people and will serve as the production hub fo
CHICAGO, July 24, 2025 -- The 2025 IFT FIRST (Food Improved by Research, Science, and Technology), one of the world's largest food science and innovation expos, recently took place from July 13 to 16 in Chicago. At the expo, Angel Yeast (SHA:600298) showcased its comprehensive, innovative lineup of yeast protein, yeast extract and baking solutions, nutritional health ingredients and brewing technologies under the themes of "Yeast Extract-Enjoy a Flavorful Life" and "Yeast Protein-Redefining Future Proteins." Angel Yeast has especially promoted the in
KUALA LUMPUR, Malaysia, July 24, 2025 -- The Aesthetic Medicine & Surgery Conference & Exhibition (AMSC) returns for its fourth edition from August 6-7, 2025, with an expanded focus on global participation and advanced education. Held at the Kuala Lumpur Convention Centre (KLCC), AMSC 2025 will feature over 160 world-class speakers, 200 international brands, and 20 supporting partners, including 13 medical societies and 7 industry collaborators. More than 1,600 delegates from around the world are expected, with highlights including clinical innovation updates, live demonstrations, and
BELLEVUE, Wash. and SEOUL, South Korea, July 24, 2025 -- OSR Holdings, Inc. (NASDAQ: OSRH), a global healthcare company advancing biomedical and wellness innovation, today announced it has signed a term sheet ("Term Sheet") with Woori IO Co., Ltd. ("WORIO"), a South Korean medical device company developing next-generation noninvasive glucose monitoring technology. The agreement sets forth certain key terms for a strategic acquisition of WORIO by OSR Holdings' Korean affiliate, OSR Holdings Co., Ltd. ("OSRK"). Under the proposed struct
밸뷰, 미국 & 서울, 대한민국 2025년 7월 24일 -- 글로벌 바이오 메디컬 기술혁신을 선도하는 헬스케어 기업 OSR Holdings, Inc. (NASDAQ: OSRH)은 비침습형 혈당 측정 기술을 개발 중인 국내 의료장비 기업인 주식회사 우리아이오 ("우리아이오")와 인수를 위한 텀싯(Term Sheet)을 체결했다고 발표했습니다. 금번 텀싯을 바탕으로 향후 실사를 거쳐 본 계약의 체결시, OSR Holdings의 한국 자회사인 주식회사 오에스알홀딩스 ("OSRK")가 우리아이오를 포괄적 주식교환 방식으로 인수하여 완전 자회사로 편입할 예정입니다. 텀싯에 따라 예상되는 거래는 OSRK가 우리아이오의 기존 주주들에게 신주를 발행하고, 이들이 일정 조건 하에 해당 주식을 미국 나스닥 상장사인 OSRH의 보통주로 전환할 수 있도록 허용하는 구조입니다. 구체적으로, 우리아이오 주주들은 1 OSRK 주식을 12.96 OSRH 주식으로 전환할 수 있는 권리를 부여받게 되며, 이는 거래 종료일로부터 3년 이내에 OSRH 주가가 최소 1회 $10.00에 도
CHICAGO, July 24, 2025 -- Fapon, a global leader in life sciences, will unveil its innovative one-stop IVD solutions at ADLM 2025, from July 29 to 31 in Chicago, IL. Fapon aims to be the trusted global partner for laboratories and IVD manufacturers with advanced innovations and dedicated localization services for the North American market. Comprehensive and Customized IVD Solutions Fapon offers a wide range of high-performance raw materials, reagent services, and open-system instruments tailored for the North American market. At ADLM, Fapon will introduce t
The first champagne crafted for conditions of zero gravity celebrates a historic mission into space REIMS, France, July 24, 2025 -- Mumm Cordon Rouge Stellar is back on Earth after its debut flight into space. On 25 June 2025, the first champagne adapted to space launched on an Axiom Space mission from Florida, returning to Earth 15 July 2025 in perfect condition in its specially designed, state-of-the-art bottle. This historic event represents the culmination of nine years of research and experimentation, during which Maison Mumm, in collaboration with a community of experts,
Fully Unmanned— CURECA™, the 100% Automated Diagnostic System Defining the Future Gold Standard, Debuts in Chicago, July 28–31 Unifying global diagnostic data - STAgora™, the big data platform set to transform the future of diagnostics Offering early access to the new diagnostic paradigm, pilot partnerships with selected institutions engaged by year-end SEOUL, South Korea, July 24, 2025 -- Seegene Inc., a global leader in molecular diagnostics, announced today that it will unveil its fully automated PCR testing system, CURECA™, and its data a
無重力環境のために作られた初のシャンパンが、 歴史的な宇宙ミッションを祝福 フランス・ランス, 2025年7月24日 -- Mumm Cordon Rouge Stellar は宇宙での初飛行を終え、地球に帰還しました。2025年6月25日、無重力に適応した初のシャンパンがフロリダから出発した Axiom Space のミッションで宇宙へと打ち上げられ、2025年7月15日、特別設計された最先端のボトルに完璧な状態で地球に帰還しました。この歴史的な出来事は、9年にわたる研究と実験の集大成であり、その間、メゾン・マムは専門家コミュニティと協力しながら、1827年の創業以来続けてきた探求をさらに押し広げ、限界に挑み続けてきました。 マルチメディアのニュースリリースをご覧になるには、以下をクリックしてください: https://www.multivu.com/g_h_mumm/9345451-en-mumm-cordon-rouge-stellar-takes-champagne-into-space この卓越したミッションの技術的偉業を超えて、Mumm Cordon Rouge Stellar は、何世紀にもわたり地上で人々を結びつけてきた祝祭と親しみの精神を象徴する存在であり、その精神は今後、宇宙へと広がってい